Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
91 Leser
Artikel bewerten:
(0)

Centinel Spine Completes Acquisition of prodisc Assets

NEW YORK, Dec. 22, 2017 /PRNewswire/ --Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodiscTotal Disc Replacement portfolio from DePuy Synthes Products, Inc. The prodisc line of products are total disc replacement (TDR) products with the longest history of use globally. The prodiscportfolio includes prodiscC and prodiscL in the United States and prodiscVIVO, prodiscNOVA, prodiscC, prodiscL, and prodiscO, along with DISCOVER' Cervical outside the United States.

Centinel Spine

This acquisition complements Centinel Spine's existing spinal implant portfolio of leading technologies for anterior column support of the spine from cervical to lumbar. This includes the company's standalone portfolio of STALIF C STALIF C-Ti', MIDLINE II', MIDLINE II-Ti', and STALIF L', as well as additional products ACTILIF' Cervical Cage TRANSOM' Plate, and ALTOSPCT.

Centinel Spine, the pioneer of the No-Profile Integrated Interbody' has a 30 year history of developing integrated interbody devices into a standard treatment for patients with degenerated disc disease. Centinel Spine will utilize the same clinical, regulatory, and development expertise to broaden acceptance and to increase carrier coverage and surgeon adoption of total discs worldwide.

"This transaction is the next step in the evolution of Centinel Spine executing on its mission to become the worldwide leading company addressing spinal disease through anterior access to the spine with the widest breadth and depth of technology platforms," said John J. Viscogliosi, Centinel Spine Chairman & CEO.

For background in understanding the acquisition, Viscogliosi Brothers, LLC, a lead investor in Centinel Spine, was the founder of Spine Solutions, Inc., the company that led the original IDE study to bring prodisc to the United States.

The company also completed debt and equity financing to close on the transaction and provide working capital. Piper Jaffray & Co. served as the sole placement agent for Centinel Spine.

About Centinel Spine, LLC.

Centinel Spine, LLC. is a privately-held spinal device company leading the development and commercialization of the No- Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company's web site at www.CentinelSpine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the "Sentinel Sign" - the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:


Varun Gandhi

Wendy F. DiCicco

SVP, Corporate Finance & Strategic Planning

Chief Operating and Chief Financial Officer

Centinel Spine, LLC

Centinel Spine, LLC

900 Airport Road, Suite 3B

900 Airport Road, Suite 3B

West Chester, PA 19380

West Chester, PA 19380

Phone: 484-887-8871

Phone: 484-887-8837

Email: v.gandhi@centinelspine.com

Email: w.dicicco@centinelspine.com

Logo - http://mma.prnewswire.com/media/370654/Centinel_Spine_Logo.jpg

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.